Skip to content

Clinical trials

Schizophrenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Germany Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20021
20036
200413
20056
20067
200714
200811
200910
20109
201111
20125
20136
20143
20158
201610
20176
20184
20192
20204
20218
20223
20233
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117
Unknown status21
Terminated19
Recruiting10
Active, not recruiting3
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Central Institute of Mental Health, Mannheim10
Universitätsklinikum Hamburg-Eppendorf10
Charite University, Berlin, Germany8
Heinrich-Heine University, Duesseldorf8
Janssen-Cilag International NV8
Ludwig-Maximilians - University of Munich7
Technical University of Munich6
University of Cologne6
Boehringer Ingelheim5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia174
Psychotic Disorders49
Schizophrenia, Paranoid10
Bipolar Disorder8
Anxiety Disorders6
Cognition Disorders6
Depressive Disorder6
Hallucinations6
Cognitive Dysfunction4
Major Depressive Disorder4

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.